793-808
Review
Protein kinase C family: On the crossroads of cell signaling in skin and tumor epithelium
D. Breitkreutz, L. Braiman-Wiksman, N. Daum, M. F. Denning and T. Tennenbaum
809-815
Review
The Epstein Barr virus DNA levels as a tumor marker in EBV-associated cancers
Paolo De Paoli, Chiara Pratesi and Maria Teresa Bortolin
817-824
Original Paper
Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR
Kenichi Kohashi, Yoshinao Oda, Hidetaka Yamamoto, Sadafumi Tamiya and Teiyu Izumi, et al.
825-834
Original Paper
Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classification
Jiefeng Cui, Xiaonan Kang, Zhi Dai, Cheng Huang and Haijun Zhou, et al.
835-840
Original Paper
CXCL5 overexpression is associated with late stage gastric cancer
Jeong Youp Park, Kyung Hwa Park, Seungmin Bang, Myoung Hwan Kim and Ji-Eun Lee, et al.
841-846
Original Paper
Combination therapy of S-1 and CDDP for patients with colorectal cancer
Kazumi Uchida, Kazuhiko Hayashi, Hidekazu Kuramochi, Go Nakajima and Yuji Inoue, et al.
847-858
Original Paper
Histone deacetylase inhibitors induce cell death and enhance the apoptosis-inducing activity of TRAIL in Ewing’s sarcoma cells
Jürgen Sonnemann, Linn Dreyer, Maite Hartwig, Chithra D. Palani and Le Thi Thu Hong, et al.
859-866
Original Paper
Importance of polymorphisms in NF-κB1 and NF-κBIα genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients
Huajie Bu, Inger Rosdahl, Xiao-Feng Sun and Hong Zhang
867-874
Original Paper
Novel germline mutations in
BRCA2
gene among 96 hereditary breast and breast–ovarian cancer families from Kerala, South India
Vani Syamala, Leelakumari Sreeja, Volga S. Syamala, B. Vinodkumar and Praveenkumar B. Raveendran, et al.
875-893
Original Paper
Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia
Jan Styczynski, Mariusz Wysocki, Robert Debski, Krzysztof Czyzewski and Beata Kolodziej, et al.
895
Erratum
Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia
Jan Styczynski, Mariusz Wysocki, Robert Debski, Krzysztof Czyzewski and Beata Kolodziej, et al.
897-901
Letter to the Editor
Anti-vascular endothelial growth factor antibody bevacizumab in conjunction with chemotherapy in metastasising melanoma
Patrick Terheyden, Maja Ann Hofmann, M. Weininger, Eva-B. Bröcker and Jürgen C. Becker
903
Letter to the Editor
Should women be advised to have first childbirth at age <20 years to reduce breast cancer risk?
Isabelle Soerjomataram and Jan Willem Coebergh